Literature DB >> 8096708

In-vitro mechanisms of 1,2-dichloropropane nephrotoxicity using the renal cortical slice model.

A Trevisan1, P Meneghetti, S Maso, O Troso.   

Abstract

1. Renal cortical slices isolated from the kidneys of male Wistar rats were used as an experimental model for studying the nephrotoxicity induced by 1,2-dichloropropane. 2. The solvent causes a depletion of renal reduced glutathione content and slight, but significant, lipid peroxidation. The block of the oxidative pathway with carbon monoxide prevents glutathione content depletion, and shows that this conjugation is the major step in 1,2-dichloropropane metabolism. 3. Loss of organic anion accumulation and release into the incubation medium of tubular enzymes, mainly from the soluble fraction, are the toxic effects of the solvent. The brush border is only slightly affected. 4. The mechanism of nephrotoxicity appears to occur via mercapturic acid metabolism. Acivicin and aminooxyacetic acid, inhibitors of gamma-glutamyltransferase and beta-lyase activity, respectively, partially but significantly prevent the loss of organic anion accumulation induced by 1,2-dichloropropane. Furthermore, alpha-ketobutyrate, an activator of beta-lyase, enhances the effects of 1,2-dichloropropane on the target, but is itself toxic for organic anion accumulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096708     DOI: 10.1177/096032719301200204

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  1 in total

1.  Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes.

Authors:  Sachiyo Mimaki; Yukari Totsuka; Yutaka Suzuki; Chikako Nakai; Masanori Goto; Motohiro Kojima; Hirofumi Arakawa; Shigekazu Takemura; Shogo Tanaka; Shigeru Marubashi; Masahiko Kinoshita; Tomonari Matsuda; Tatsuhiro Shibata; Hitoshi Nakagama; Atsushi Ochiai; Shoji Kubo; Shoji Nakamori; Hiroyasu Esumi; Katsuya Tsuchihara
Journal:  Carcinogenesis       Date:  2016-06-07       Impact factor: 4.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.